Economic Evaluation of Ramucirumab as Second-Line Chemotherapy for Previously Treated Advanced Gastric or Gastro-Oesophageal Junction Adenocarcinoma in China
Abstract
Authors
X Luo L Peng C Tan X Wan X Zeng
X Luo L Peng C Tan X Wan X Zeng
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now